MedTrace Logo

Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients

NCT05202340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-06-01

No results posted yet for this study

Summary

The objective of this study is to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients. This is a cross-sectional study performed in Prince of Wales Hospital in Hong Kong. One hundred patients will be recruited for this study.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Chi Fai NG, MD · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-07
Primary Completion
2022-12-31
Completion
2023-02-28

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05202340 on ClinicalTrials.gov